Therapeutic Class | Number (%) | |
---|---|---|
Prednisone | None 0.5-15 mg/day >15 mg/day | 268 (70.7%) 104 (27.4%) 7 (1.9%) |
DMARDs, Total Exposed |
Methotrexate Hydroxychloroquine Sulfasalazine Leflunomide Combination DMARDs |
235 (61.2%) 145 (38.1%) 117 (30.7%) 20 (5.3%) 34 (8.9%) 84 (22.1%) |
Biologics, Total Exposed |
Infliximab Adalimumab Etanercept Golimumab Anakinra Abatacept Rituximab |
70 (18.4%) 14 (3.7%) 15 (3.9%) 36 (9.5%) 1 (0.3%) 2 (0.5%) 1 (0.3%) 1 (0.3%) |